Iida Kaori, Proctor Robert N
Department of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Lancet. 2004 May 29;363(9423):1820-4. doi: 10.1016/S0140-6736(04)16310-1.
Japan is in the midst of a rapid increase in tobacco-related disease mortality, following the rapid growth of smoking after WWII. Stomach cancer was the country's leading cause of cancer death for most of the 20th century, until lung cancer took over this position in 1993. Cigarettes are the major cause of lung cancer in Japan, but the country's leading manufacturer, Japan Tobacco, two thirds of which is owned by the Japanese government, continues to question whether tobacco is a major cause of disease and death. Japanese courts do not have the power to subpoena a company's internal records, which has made it difficult to document Japan Tobacco's strategies concerning tobacco and health. Our interpretation of online archives of internal documents from American tobacco companies, however, is that Japan Tobacco has long known about the potential health risks involved in smoking and has sought to obstruct effective tobacco control. Beginning in the mid-1980s, these efforts were often co-ordinated with American tobacco manufacturers. The documentary evidence shows that cigarette manufacturer Philip Morris in particular assisted with and sometimes also supervised Japan Tobacco's actions and statements on smoking and health. In one instance, data gathered for an article published by the Japan Public Monopoly Corporation (Japan Tobacco's predecessor) were deliberately altered to lower the reported value of a hazard indicator (nicotine concentration in the air). International collaboration has made it easier for companies such as Japan Tobacco to develop effective anti-antismoking strategies. Evidence of such global industry collaborations might grow as lawsuits begin to be filed in other nations.
二战后吸烟人数迅速增长,日本正处于与烟草相关疾病死亡率快速上升的阶段。在20世纪的大部分时间里,胃癌一直是该国癌症死亡的主要原因,直到1993年肺癌取代了这一位置。香烟是日本肺癌的主要病因,但该国最大的制造商日本烟草公司(其中三分之二为日本政府所有)仍在质疑烟草是否是疾病和死亡的主要原因。日本法院无权传唤公司内部记录,这使得记录日本烟草公司在烟草与健康方面的策略变得困难。然而,我们对美国烟草公司内部文件在线档案的解读是,日本烟草公司早就知道吸烟所涉及的潜在健康风险,并试图阻碍有效的烟草控制。从20世纪80年代中期开始,这些努力常常与美国烟草制造商协调进行。书面证据表明,尤其是香烟制造商菲利普·莫里斯公司协助并有时还监督日本烟草公司在吸烟与健康问题上的行动和声明。有一个例子是,为日本公共垄断公司(日本烟草公司的前身)发表的一篇文章收集的数据被故意篡改,以降低报告的一个危害指标(空气中尼古丁浓度)的值。国际合作让日本烟草这样的公司更容易制定有效的反吸烟策略。随着其他国家开始提起诉讼,这种全球行业合作的证据可能会增加。